Print Share

SmartPill: an ingestible diagnostic-sensing capsule that measures how the gastrointestinal tract is functioning

Institution:

Jacobs School of Medicine and Biomedical Sciences, the University at Buffalo

Researchers:

Michael D. Sitrin, MD, professor of medicine at University at Buffalo Jacobs School of Medicine and Biomedical Sciences, co-directed the seven-site clinical trial of the SmartPill

Impact:

The diagnosis and treatment of gastrointestinal (GI) disorders have been greatly improved by the SmartPill, an ingestible diagnostic sensing capsule that travels every inch of the 30-foot-long human GI tract while making and recording key measurements.

Timeline:

In 2006, the SmartPill received approval by the Food and Drug Administration. Three years later, it was highlighted in a Forbes magazine story on cutting-edge life-saving technologies.

Topics

AgingBasic ScienceCancerCardiovascularClinical ResearchDiagnosticsDrug DevelopmentFeaturedGeneticsImmune SystemInfectious DiseaseMedical DeviceMental HealthNeurodegenerativeNobel PrizePediatricsPublic HealthRespiratorySurgical AdvancementTechnologyTreatment AdvancesVaccines

Schools

Albany Medical CollegeAlbert Einstein College of MedicineCity University of New York School of MedicineColumbia University College Of Physicians and SurgeonsHofstra Northwell School of Medicine at Hofstra UniversityIcahn School of Medicine at Mount SinaiJacobs School of Medicine and Biomedical Sciences, the University at BuffaloNew York Institute of Technology College of Osteopathic MedicineNew York Medical CollegeNew York University School of MedicineSchool of Medicine and Dentistry at the University of Rochester Medical CenterStony Brook University School of MedicineSUNY Downstate Medical CenterSUNY Upstate Medical UniversityTouro College of Osteopathic MedicineWeill Cornell MedicineWeill Cornell Medicine, NewYork-Presbyterian